81 related articles for article (PubMed ID: 8334261)
41. [The development of clinical high tesla MRI/S system].
Ikehira H; Hashimoto T; Iinuma TA
Nihon Rinsho; 1991 Jul; 49(7):1627-33. PubMed ID: 1886261
[No Abstract] [Full Text] [Related]
42. [Cardiac insufficiency from the standpoint of myocardial metabolism].
KOBAYASHI T
Naika; 1962 Apr; 9():615-8. PubMed ID: 14457479
[No Abstract] [Full Text] [Related]
43. [On cardiac insufficiency due to disorders of myocardial metabolism and its treatment].
OTTO H
Z Gesamte Inn Med; 1959 Nov; 14():985-91. PubMed ID: 14429413
[No Abstract] [Full Text] [Related]
44. The true T1 values of myocardial high-energy phosphates?
Bottomley PA
Magn Reson Med; 1993 Jan; 29(1):145-7. PubMed ID: 8419737
[No Abstract] [Full Text] [Related]
45. Cardiac insufficiency: a critical analysis of the current publication procedures under quantitative and qualitative aspects.
Vitzthum K; Scutaru C; Quarcoo D; Mache S; Groneberg DA; Schöffel N
J Cardiothorac Vasc Anesth; 2010 Aug; 24(4):731-4. PubMed ID: 19632859
[No Abstract] [Full Text] [Related]
46. [Existence of an energetico-dynamic form of cardiac insufficiency].
LEGRAND R; DESRUELLES J; MERLEN JF; BOURET G
Arch Mal Coeur Vaiss; 1959 Jul; 52():740-52. PubMed ID: 14415340
[No Abstract] [Full Text] [Related]
47. [Prognostic factors of chronic heart insufficiency].
Roul G; Bareiss P
Ann Cardiol Angeiol (Paris); 2001 Feb; 50(1):21-9. PubMed ID: 12555388
[No Abstract] [Full Text] [Related]
48. Cardiac muscle; further studies; investigation of chemical changes in myocardial insufficiency with special reference to adenosinetriphosphate.
MANGUN GH; MYERS VC
Arch Intern Med (Chic); 1946 Oct; 78(4):441-6. PubMed ID: 20273968
[No Abstract] [Full Text] [Related]
49. [Clinical possibilities in differentiation of myocardial insufficiency].
AGOSTONI G
Bibl Cardiol; 1959; 9():75-81. PubMed ID: 13792050
[No Abstract] [Full Text] [Related]
50. [The role of the sinus and cardio-aortic regions in the flexible regulation of cardiac output].
CHARLIER R
Acta Cardiol; 1948; 3(1):1-47. PubMed ID: 18909146
[No Abstract] [Full Text] [Related]
51. Lactate and Myocardiac Energy Metabolism.
Dong S; Qian L; Cheng Z; Chen C; Wang K; Hu S; Zhang X; Wu T
Front Physiol; 2021; 12():715081. PubMed ID: 34483967
[TBL] [Abstract][Full Text] [Related]
52. Loss of Metabolic Flexibility in the Failing Heart.
Karwi QG; Uddin GM; Ho KL; Lopaschuk GD
Front Cardiovasc Med; 2018; 5():68. PubMed ID: 29928647
[TBL] [Abstract][Full Text] [Related]
53. 31P-MR spectroscopic imaging in hypertensive heart disease.
Heyne JP; Rzanny R; Hansch A; Leder U; Reichenbach JR; Kaiser WA
Eur Radiol; 2006 Aug; 16(8):1796-802. PubMed ID: 16514468
[TBL] [Abstract][Full Text] [Related]
54. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.
Hansch A; Rzanny R; Heyne JP; Leder U; Reichenbach JR; Kaiser WA
Eur Radiol; 2005 Feb; 15(2):319-23. PubMed ID: 15630572
[TBL] [Abstract][Full Text] [Related]
55. [31P-cardio-MR-spectroscopy in myocardial insufficiency].
Krahe T; Schindler R; Neubauer S; Ertl G; Horn M; Lackner K
Rofo; 1993 Jul; 159(1):64-70. PubMed ID: 8334261
[TBL] [Abstract][Full Text] [Related]
56. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
[TBL] [Abstract][Full Text] [Related]
57. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
Beer M; Sandstede J; Weilbach F; Spindler M; Buchner S; Krug A; Köstler H; Pabst T; Kenn W; Landschütz W; von Kienlin M; Toyka KV; Ertl G; Gold R; Hahn D
Rofo; 2001 May; 173(5):399-404. PubMed ID: 11414146
[TBL] [Abstract][Full Text] [Related]
58. MR spectroscopy of the heart.
Sardanelli F; Quarenghi M
Radiol Med; 2006 Dec; 111(8):1025-34. PubMed ID: 17171530
[TBL] [Abstract][Full Text] [Related]
59. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
[TBL] [Abstract][Full Text] [Related]
60. Cardiac MR spectroscopy in the new millennium.
Pohost GM; Meduri A; Razmi RM; Rathi VK; Doyle M
Rays; 2001; 26(1):93-107. PubMed ID: 11471351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
